Is this recently characterized gastrointestinal pathogen responsible for rising rates of inflammatory bowel disease (IBD) and IBD associated autism in Europe and the United States in the 1990s?

Medical Hypotheses

Volumn 69, Issue 3, 2007, Pages 652-659

  Boorom, Kenneth Fiske ^a  

^a Blastocystis Research Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTISM; BLASTOCYSTIS; DISEASE ASSOCIATION; ENTERITIS; EUROPE; HOST RANGE; HUMAN; HYPOTHESIS; IRRITABLE COLON; PARASITE VIRULENCE; PRIORITY JOURNAL; UNITED STATES;

ANIMALS; AUTISTIC DISORDER; BLASTOCYSTIS; BLASTOCYSTIS INFECTIONS; ENTAMOEBA HISTOLYTICA; EUROPE; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; MODELS, BIOLOGICAL; MODELS, THEORETICAL; TIME FACTORS; TRAVEL; UNITED STATES;

ANIMALIA; BLASTOCYSTIS; ENTAMOEBA;

EID: 34447290036     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.01.027     Document Type: Article

References (50)

1. Bercik P., Verdu E.F., and Collins S.M. Is irritable bowel syndrome a low-grade inflammatory bowel disease?. Gastroenterol Clin North Am 34 2 (2005) 235-245 vi-vii
2. Garcia Rodriguez L.A., Ruigomez A., Wallander M.A., Johansson S., and Olbe L. Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome. Scand J Gastroenterol 35 3 (2000) 306-311
3. Qadri S.M., al-Okaili G.A., and al-Dayel F. Clinical significance of Blastocystis hominis. J Clin Microbiol 27 11 (1989) 2407-2409
4. Zierdt C.H. Blastocystis hominis-past and future. Clin Microbiol Rev 4 1 (1991) 61-79
5. Boorom F., and Kenneth. Commensal and pathogenic Blastocystis with case studies from Oregon's Willamette Valley (2006), BRF Press. http://www.bhomcenter.org/index.htm ISBN 978-1-4303-0904-8, Portions available on foundation web site
6. Markell E.K., and Udkow M.P. Association of Blastocystis hominis with human disease?. J Clin Microbiol 28 5 (1990) 1085-1086
7. Rosenblatt J.E. Blastocystis hominis. J Clin Microbiol 28 10 (1990) 2379-2380
8. Ho L.C., Jeyaseelan K., and Singh M. Use of the elongation factor-1 alpha gene in a polymerase chain reaction-based restriction-fragment-length polymorphism analysis of genetic heterogeneity among Blastocystis species. Mol Biochem Parasitol 112 2 (2001) 287-291
9. McGowan K., Guerina V., Wicks J., and Donowitz M. Secretory hormones of Entamoeba histolytica. Ciba Found Symp 112 (1985) 139-154
10. McGowan K., et al. Entamoeba histolytica causes intestinal secretion: role of serotonin. Science 221 4612 (1983) 762-764 August 19
11. Banu, Naheed, et al. Neurohumoral alterations and their role in amoebiasis. Ind J Clin Biochem 20 2 (2005) 142-145
12. Vaeroy H., Helle R., Forre O., Kass E., and Terenius L. Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis. Pain 32 1 (1988) 21-26
13. Evers B.M. Neurotensin and growth of normal and neoplastic tissues. Peptides 27 10 (2006) 2424-2433
14. Eckmann L., Reed S.L., Smith J.R., and Kagnoff M.F. Entamoeba histolytica trophozoites induce an inflammatory cytokine response by cultured human cells through the paracrine action of cytolytically released interleukin-1 alpha. J Clin Invest 96 3 (1995) 1269-1279
15. Gomes-Pereira S., Rodrigues O.R., Rolao N., Almeida P.D., and Santos-Gomes G.M. Hepatic cellular immune responses in mice with "cure and "non-cure" phenotype to Leishmania infantum infection: importance of CD8+ T cells and TGF-beta production. FEMS Immunol Med Microbiol 41 1 (2004) 59-68
16. Noel C., et al. Molecular phylogenies of Blastocystis isolates from different hosts: implications for genetic diversity, identification of species, and zoonosis. J Clin Microbiol 43 1 (2005) 348-355
17. Tan T.C., Suresh K.G., Thong K.L., and Smith H.V. PCR fingerprinting of Blastocystis isolated from symptomatic and asymptomatic human hosts. Parasitol Res 21 (2006)
18. Puthia M.K., Sio S.W., Lu J., and Tan K.S. Blastocystis ratti induces contact-independent apoptosis, F-actin rearrangement, and barrier function disruption in IEC-6 cells. Infect Immun 74 7 (2006) 4114-4123
19. Suresh K., and Smith H. Comparison of methods for detecting Blastocystis hominis. Eur J Clin Microbiol Infect Dis 23 6 (2004) 509-511
20. Stensvold, Rune, et al. Detection of Blastocystis hominis in unpreserved stool specimens by using polymerase chain reaction. J Parasitol (2006) 1081-1087
21. Parkar U., Traub R.J., Kumar S., Mungthin M., Vitali S., Leelayoova S., et al. Direct characterization of Blastocystis from faeces by PCR and evidence of zoonotic potential. Parasitology 19 Oct (2006) 1-9
22. Suresh K., Smith H.V., and Tan T.C. Viable Blastocystis cysts in Scottish and Malaysian sewage samples. Appl Environ Microbiol 71 9 (2005) 5619-5620
23. Zierdt C.H., and Nagy B. Antibody response to Blastocystis hominis infections. Ann Intern Med 118 12 (1993) 985-986
24. Hussain R., Jaferi W., Zuberi S., Baqai R., Abrar N., Ahmed A., et al. Significantly increased IgG2 subclass antibody levels to Blastocystis hominis in patients with irritable bowel syndrome. Am J Trop Med Hyg 56 3 (1997) 301-306
25. Croonenberghs J., Wauters A., Devreese K., Verkerk R., Scharpe S., Bosmans E., et al. Increased serum albumin, gamma globulin, immunoglobulin IgG, and IgG2 and IgG4 in autism. Psychol Med 32 8 (2002) 1457-1463
26. Mawe G.M., Coates M.D., and Moses P.L. Review article: intestinal serotonin signalling in irritable bowel syndrome. Aliment Pharmacol Ther 23 8 (2006) 1067-1076
27. Cominelli F., and Pizarro T.T. Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease. Aliment Pharmacol Ther 10 Suppl 2 (1996) 49-53
28. Long H.Y., Handschack A., Konig W., and Ambrosch A. Blastocystis hominis modulates immune responses and cytokine release in colonic epithelial cells. Parasitol Res 87 12 (2001) 1029-1030
29. Cole J.A., Rothman K.J., Cabral H.J., Zhang Y., and Farraye F.A. Migraine, fibromyalgia, and depression among people with IBS: a prevalence study. BMC Gastroenterol 6 Sep 28 (2006) 26
30. Zhang Z., Mahajan S., Zhang X., and Stanley Jr. S.L. Tumor necrosis factor alpha is a key mediator of gut inflammation seen in amebic colitis in human intestine in the SCID mouse-human intestinal xenograft model of disease. Infect Immun 71 9 (2003) 5355-5359
31. Rutgeerts P., et al. Rifabutin and ethambutol do not help recurrent Crohn's disease in the neoterminal ileum. J Clin Gastroenterol 15 1 (1992) 24-28
32. Borody T.J., Leis S., Warren E.F., and Surace R. Treatment of severe Crohn's disease using antibiotic triple therapy-approaching a cure?. Dig Liver Dis 34 1 (2002) 29-38
33. Lindberg E., Lindquist B., Holmquist L., and Hildebrand H. Inflammatory bowel disease in children and adolescents in Sweden, 1984-1995. J Pediatr Gastroenterol Nutr 30 3 (2000) 259-264
34. Armitage E., Drummond H.E., Wilson D.C., and Ghosh S. Increasing incidence of both juvenile-onset Crohn's disease and ulcerative colitis in Scotland. Eur J Gastroenterol Hepatol 13 12 (2001) 1439-1447
35. Vind I., Riis L., Jess T., Knudsen E., Pedersen N., Elkjaer M., et al., The DCCD study group. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol 101 6 (2006) 1274-1282
36. Turunen P., Kolho K.L., Auvinen A., Iltanen S., Huhtala H., and Ashorn M. Incidence of inflammatory bowel disease in Finnish children, 1987-2003. Inflamm Bowel Dis 12 8 (2006) 677-683
37. Bernstein C.N., Rawsthorne P., Cheang M., and Blanchard J.F. A population-based case control study of potential risk factors for IBD. Am J Gastroenterol 101 5 (2006) 993-1002
38. De Backer A.I., De Schepper A.M., and Pelckmans P. Polypoid and pseudopolypoid lesions of inflammatory bowel disease: diagnosis on double-contrast enema. Acta Gastroenterol Belg 62 2 (1999) 190-195
39. Guilarte M., et al. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut 27 Sep (2006)
40. Jafri W., Yakoob J., Jafri N., Islam M., and Ali Q.M. Frequency of irritable bowel syndrome in college students. J Ayub Med Coll Abbottabad 17 4 (2005) 9-11
41. Tan T.C., and Suresh K.G. Amoeboid form of Blastocystis hominis-a detailed ultrastructural insight. Parasitol Res 99 6 (2006) 737-742
42. Afzal N., Murch S., Thirrupathy K., Berger L., Fagbemi A., and Heuschkel R. Constipation with acquired megarectum in children with autism. Pediatrics 112 4 (2003) 939-942
43. Warren R.P., and Singh V.K. Elevated serotonin levels in autism: association with the major histocompatibility complex. Neuropsychobiology 34 2 (1996) 72-75
44. Ashwood P., and Wakefield A.J. Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms. J Neuroimmunol 173 1-2 (2006) 126-134
45. DeFelice M.L., et al. Intestinal cytokines in children with pervasive developmental disorders. Am J Gastroenterol 98 8 (2003) 1777-1782
46. Smeeth L., Cook C., Fombonne P.E., Heavey L., Rodrigues L.C., Smith P.G., et al. Rate of first recorded diagnosis of autism and other pervasive developmental disorders in United Kingdom general practice, 1988-2001. BMC Med 2 9 (2004) 39
47. Olmsted, and Dan. The age of autism: the amish anomaly (2005), United Press International, The Washington Times April 18
48. Wakefield A.J., Ashwood P., Limb K., and Anthony A. The significance of ileo-colonic lymphoid nodular hyperplasia in children with autistic spectrum disorder. Eur J Gastroenterol Hepatol 17 8 (2005) 827-836
49. Barbaresi W.J., Katusic S.K., Colligan R.C., Weaver A.L., and Jacobsen S.J. The incidence of autism in Olmsted County, Minnesota, 1976-1997: results from a population-based study. Arch Pediatr Adolesc Med 159 1 (2005) 37-44
50. Korn, and Peter. Can rain explain autism?. Portland Tribune 2 November (2006)